Mao Sheng Duan
Corporate Officer/Principal chez HD Biosciences Co., Ltd.
Profil
Mao Sheng Duan is currently the Vice President & Head-Medicinal Chemistry at HD Biosciences Co., Ltd.
Prior to this, he worked as the Chief Scientist at Glaxosmithkline China Ltd.
Dr. Duan received his doctorate degree from The Ohio State University and his undergraduate and graduate degrees from Central China Normal University and Nankai University respectively.
Postes actifs de Mao Sheng Duan
| Sociétés | Poste | Début |
|---|---|---|
HD Biosciences Co., Ltd.
 HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Anciens postes connus de Mao Sheng Duan
| Sociétés | Poste | Fin |
|---|---|---|
| Glaxosmithkline China Ltd. | Corporate Officer/Principal | - |
Formation de Mao Sheng Duan
| Central China Normal University | Undergraduate Degree |
| Nankai University | Graduate Degree |
| The Ohio State University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
HD Biosciences Co., Ltd.
HD Biosciences Co., Ltd. Medical/Nursing ServicesHealth Services HD Biosciences Co., Ltd. operates as a biotech company. It specializes in drug discovery contract research. The company offers comprehensive technology platforms and expertise services around hit to lead and lead optimization in preclinical drug discovery and development, which includes biology assays and assay development, compound profiling, high throughput screening, DMPK, in vivo pharmacology, drug efficacy and safety, as well as natural product based lead compound discovery. The company was founded in October 2002 and is headquartered in Shanghai, China. | Health Services |
| Glaxosmithkline China Ltd. |